Condition

Early Stage Triple-Negative Breast Carcinoma clinical trials and research

• 6Clinical trials
• 4Countries

Newest Early Stage Triple-Negative Breast Carcinoma clinical trials

All recruiting trials (6)

• Adjunct Therapy De-escalation in Early HER2+ and TNBC After Neoadjuvant Response

  This phase 2 trial tests stopping certain post-surgery immunotherapy and targeted therapies early in people with early HER2+ or triple-negative breast cancer who have no detectable cancer DNA after neoadjuvant treatment and surgery.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT07407920

• Ivonescimab with carboplatin and docetaxel for early triple-negative breast cancer

  This trial will test whether adding ivonescimab to neoadjuvant carboplatin and docetaxel helps people with early-stage triple-negative breast cancer.

  Recruiting at 3 sites Phase 2 Cedars-Sinai Medical Center · Los Angeles, California and 3 other locations · NCT07017673

• Predicting how tumors respond to immune therapies using a live diagnostic platform

  This study is testing a new way to predict how well immune therapies will work for patients with different types of solid tumors, including early-stage and metastatic cancers.

  Recruiting at 3 sites Mayo Clinic · Phoenix, Arizona and 2 other locations · NCT06349642

• Personalized tumor vaccine with checkpoint inhibitors for triple negative breast cancer

  This phase I trial will test whether a personalized tumor membrane vesicle (TMV) vaccine, given alone or with pembrolizumab or ipilimumab, can boost immune response and help control disease in adults with triple negative breast cancer.

  Recruiting at 4 sites Phase 1 Emory University · Atlanta, Georgia and 3 other locations · NCT06324240

• Shorter chemotherapy and immunotherapy for early-stage triple negative breast cancer

  This study is testing whether a shorter treatment plan of chemotherapy and immunotherapy without certain strong drugs can help people with early-stage triple negative breast cancer do better than the usual longer treatment.

  Recruiting at 923 sites Phase 3 SWOG Cancer Research Network · Birmingham, Alabama and 962 other locations · NCT05929768

• Comparing pembrolizumab to observation for early-stage triple-negative breast cancer after chemotherapy

  This study tests whether a drug called pembrolizumab can help prevent the return of early-stage triple-negative breast cancer after chemotherapy, compared to just keeping an eye on patients without extra treatment.

  Recruiting at 797 sites Phase 3 Alliance for Clinical Trials in Oncology · Birmingham, Alabama and 845 other locations · NCT05812807

Related topics

Quick answers

How many Early Stage Triple-Negative Breast Carcinoma clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (6 trials), Puerto Rico (2 trials), Mexico (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 3: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →